Replies to post #134920 on Biotech Values

[DewDiligence]

ONTY…surprised this one won a spot in even your charity portfolio.

In such a contest, where there are manifold entrants and there is no second-place prize, you want to pick stocks with a high variance so you have a chance to win if something positive actually happens during the year. On the other hand, if a contest selection crashes and burns, it doesn’t hurt your winning chances in the contest by that much more than a stock that flatlines.

For the above reason, no one should confuse a set of selections in the SI Charity Contest (or any similar contest) with real-world biotech investing.

[BTH]

Yeah, I agree. Thankfully, Merck has control over the Stimuvax program. I think Kirkman is kind of a babbling idiot. Not a scummy one like a lot of CEO's, just simply, a marble-mouth.

But then again, who knows what he really said. It was done by Reuters and those guys are clowns and misquote all the time.

[mcbio]

And a bonus quote re their PI3K program..."hopefully some competitors' will fail and the partners will come to us then"

ONTY's CEO really said that? That's a pretty ridiculous statement to make. Why would you say that? Gives absolutely no confidence to your own drug at all. I thought their pan-PI3K inhibitor sounded like it might be differentiated from a lot of the competition. That kind of assertion makes me think otherwise.